Additional file 1 of A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort
Additional file 1. Lymphoma subtypes included and excluded in the study, according to the 2016 WHO classification. Detailed list of lymphoma subtypes included and excluded of the study.
Funding
Roche Celgene International II SARL Takeda France SAS Janssen-Cilag Amgen SAS